These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1172906)

  • 1. Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, testosterone, and seminal fluid analyses in normal men.
    Mauss J; Börsch G; Bormacher K; Richter E; Leyendecker G; Nocke W
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):373-84. PubMed ID: 1172906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
    Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
    Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
    J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular function in a birth cohort of young men.
    Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
    Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control.
    Føgh M; Corker CS; McLean H; Hunter WM; Petersen IB; Philip J; Schou G; Skakkebaek NE
    Acta Endocrinol (Copenh); 1980 Oct; 95(2):251-7. PubMed ID: 6776755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male.
    Lübbert H; Leo-Rossberg I; Hammerstein J
    Fertil Steril; 1992 Sep; 58(3):603-8. PubMed ID: 1387850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men.
    Morse HC; Leach DR; Rowley MJ; Heller CG
    J Reprod Fertil; 1973 Mar; 32(3):365-78. PubMed ID: 4692335
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigations on the use of testosterone oenanthate as a male contraceptive agent.
    Mauss J; Börsch G; Richter E; Bormacher K
    Contraception; 1974 Sep; 10(3):281-9. PubMed ID: 4374338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
    Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
    Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
    Føgh M; Corker CS; Hunter WM; McLean H; Philip J; Schou G; Skakkebaek NE
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of administration of a single dose of testosterone oenanthate on constituents of human seminal plasma and serum gonadotropins.
    Sheth AR; Jayatilak PG; Thakur AN; Mugatwala P; Pardanani DS
    Andrologia; 1976; 8(3):259-64. PubMed ID: 999044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum FSH levels correlated with low and high sperm counts in male infertile patients.
    Sina D; Schuhmann R; Abraham R; Taubert HD; Dericks-Tan JS
    Andrologia; 1975; 7(1):31-7. PubMed ID: 1163822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of male fertility by 1,2,3-trihydroxypropane (THP;glycerol): rapid arrest of spermatogenesis without altering libido, accessory organs, gonadal steroidogenesis, and serum testosterone, LH and FSH.
    Wiebe JP; Barr KJ
    Contraception; 1984 Mar; 29(3):291-302. PubMed ID: 6428807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.